University Hospitals Cleveland Medical Center

University Hospitals Surpasses $5 Million in Community Support in Fight Against COVID-19

Community foundations lead with substantial grant funding

Newswise — CLEVELAND – More than $5 million in community giving is helping to support University Hospitals’ response to the ongoing COVID-19 health crisis. Contributions from community hospital foundations, totaling $2.25 million, and a $1 million clinical research grant from the Cleveland Foundation represent a significant portion of the funds contributed to date and will provide crucial, local-level support during the pandemic.

“Our caregivers are making untold sacrifices to meet this challenge unlike any other in our lifetimes,” said Thomas F. Zenty III, CEO, University Hospitals. “While this pandemic may feel daunting, we have a resilient team and a dedicated community who are all demonstrating strength beyond measure.”

Challenge grants of $500,000 each – awarded by Elyria Medical Center Foundation, Parma Hospital Health Care Foundation, Portage Medical Center Foundation and Samaritan Hospital Foundation – will support the COVID-19 Community Response Funds at each of the foundation’s affiliated UH medical centers. Leading by example, the four hospital foundations hope the new challenge grants inspire others to join them in supporting their local UH medical centers.

“During this unprecedented time, I think all of us at community hospital foundations feel the same – it is crucial that we show our support for our local UH medical centers and the dedicated caregivers that work there,” said Richard Beal, President, Samaritan Hospital Foundation.

An additional $250,000 gift from Rainbow Babies & Children’s Foundation will help UH’s nationally recognized children’s hospital withstand the COVID-19 crisis and emerge strong. “It is vitally important that we help UH Rainbow face this challenge head-on and ensure that they’re well-positioned to meet the post-crisis needs of our patients and families,” said Rainbow Foundation President, Terri A. Kennedy.

Recognizing the unprecedented challenges faced by caregivers at health systems throughout Northeast Ohio and the critical role they will continue to play in ensuring the recovery and resilience of the community, the Cleveland Foundation authorized $1 million in emergency funding from previously restricted health-related research grant dollars to support a significant portion of a UH-led clinical trial of ARMS-I, an investigational drug that may prevent airborne transmission of coronavirus. The ARMS-I study is one of the COVID-19-related trials and research initiatives underway at the academic medical center thanks to critical research support from the UH COVID-19 Community Response Fund.

In addition to local community foundations, individuals, corporations and family foundations across the region have responded to the crisis with overwhelming compassion, generously supporting UH’s COVID-19 Community Response Fund and COVID-19 Caregiver Support Fund. Contributions to the two funds – including lead donations from the Vinchel Family, Amy and Michael Southard, Bank of America and Hyundai Hope on Wheels – are helping defray the unanticipated costs of the health crisis, ranging from extensive patient care and testing, medical supplies and research to providing for the protection, wellness and resilience of UH caregivers.

Donations of personal protective equipment, critical care supplies and homemade fabric facemasks – cumulatively valued at more than $500,000 – are further supporting UH and its frontline caregivers.

“University Hospitals has a long-standing commitment to the health and well-being of our community, a promise that we extended in recent years with the health system’s regional expansion,” said UH Chief Operating Officer, Eric Beck, DO, MPH. “Today, that promise is more important than ever and we are grateful to have wide-spread support throughout Northeast Ohio and beyond as we face this pandemic together.”

Community members can learn about ways to support UH and its caregivers during the COVID-19 health crisis at UHGiving.org/coronavirus.

###

 About University Hospitals

Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 50 health centers and outpatient facilities, and 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; University Hospitals Harrington Heart & Vascular Institute, a high-volume national referral center for complex cardiovascular procedures; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is one of the largest employers in Northeast Ohio with 28,000 physicians and employees. Advancing the Science of Health and the Art of Compassion is UH’s vision for benefitting its patients into the future, and the organization’s unwavering mission is To Heal. To Teach. To Discover. Follow UH on LinkedIn, Facebook @UniversityHospitals and Twitter @UHhospitals. For more information, visit UHhospitals.org.

 




Filters close

Showing results

110 of 3821
Newswise: UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
Released: 28-Oct-2020 5:20 PM EDT
UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
UC Davis Health

UC Davis Health is one of only a handful of health systems in the U.S. to launch a Post-COVID-19 Clinic to care for long-haul COVID patients whose symptoms go on and on, sometimes for months, with no clear explanation or avenue for treatment.

Newswise: Most People Mount a Strong Antibody Response to 
SARS-CoV-2 That Does Not Decline Rapidly
Released: 28-Oct-2020 5:20 PM EDT
Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly
Mount Sinai Health System

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

Newswise: 45a1c2a0-c0a4-11ea-b53e-cb3f2ed770b1.jpg
Released: 28-Oct-2020 4:00 PM EDT
Investigator on the AtraZeneca vaccine trial will take questions at Live Event on Oct. 29, 3PM
Keck Medicine of USC

Dr. Edward Jones-Lopez, joins a Newswise Live Expert Panel on Thursday Oct. 29, from 3-4 PM EDT to discuss the AstraZenea COVID-19 vaccine trial.

Released: 28-Oct-2020 4:00 PM EDT
"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT
Newswise

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

Newswise: Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Released: 28-Oct-2020 2:15 PM EDT
Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Oak Ridge National Laboratory

A collaboration between the Department of Energy’s Oak Ridge National Laboratory and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

Released: 28-Oct-2020 1:55 PM EDT
What EEGs tell us about COVID-19 and the brain
Baylor College of Medicine

Throughout the pandemic, healthcare workers have seen more than just the lungs affected by COVID-19. Doctors have reported neurological complications including stroke, headache and seizures, but the information is limited to a number of individual reports that are not reflective of a larger population.

Released: 28-Oct-2020 1:50 PM EDT
A new playbook: COVID-19, athletes' hearts and return to play
Massachusetts General Hospital

Reports have indicated that COVID-19 may cause heart damage in hospitalized patients with severe cases of the disease, but it's unclear whether cardiac injury also occurs in infected patients who are asymptomatic or experience only mild symptoms.

Newswise: 0815UCI20052-1069-768x512.jpg
Released: 28-Oct-2020 1:05 PM EDT
Antibody screening finds COVID-19 nearly 7 times more prevalent in O.C. than thought
University of California, Irvine

Irvine, Calif., Oct. 28, 2020 — Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent. Latino and low-income residents had the highest prevalence of SARS-CoV-02 antibodies with rates of 17 percent and 15 percent, respectively.

Released: 28-Oct-2020 1:05 PM EDT
Researchers find confusion over masks for wildfire, COVID-19 crises
Stanford School of Earth, Energy & Environmental Sciences

To mask or not to mask - and which mask to use? With public health guidance about masks in the United States confused by political hedging, clarity around mask use is increasingly important, especially as the western U.S. battles the twin crises of wildfire smoke and COVID-19.


Showing results

110 of 3821

close
0.92094